Switzerland Pharmaceuticals

Vifor Pharma AG (VIFN)

Track

Track

Vifor Pharma AG recorded two insider trading transactions over the past ninety days, both involving sales totaling 445,275 CHF. These divestments follow a period of varied buying activity observed throughout late 2025. The company last published its earnings report in September 2022, providing historical context for these recent equity movements.
Ticker: VIFN Exchange: VTX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Vifor Pharma AG. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Executive Director / Officer
Transaction date
Sale
Price
181.18
Quantity 98,715
Value CHF26,436
Executive Director / Officer
Transaction date
Sale
Price
278.15
Quantity 5,943
Value CHF3,989,991
Executive Director / Officer
Transaction date
Sale
Price
60.75
Quantity 88,063
Value CHF1,008,390
Non-Executive Director
Transaction date
Purchase
Price
60,000.00
Quantity 1
Value CHF60,000
Non-Executive Director
Transaction date
Purchase
Price
75,000.00
Quantity 1
Value CHF75,000
Non-Executive Director
Transaction date
Purchase
Price
45,000.00
Quantity 1
Value CHF45,000
Non-Executive Director
Transaction date
Purchase
Price
70,000.00
Quantity 1
Value CHF70,000
Non-Executive Director
Transaction date
Purchase
Price
175,000.00
Quantity 1
Value CHF175,000
Executive Director / Officer
Transaction date
Purchase
Price
61.75
Quantity 80
Value CHF4,940
Executive Director / Officer
Transaction date
Purchase
Price
61.75
Quantity 80
Value CHF4,940
Executive Director / Officer
Transaction date
Purchase
Price
61.75
Quantity 80
Value CHF4,940
Executive Director / Officer
Transaction date
Purchase
Price
61.75
Quantity 80
Value CHF4,940
Executive Director / Officer
Transaction date
Purchase
Price
61.75
Quantity 80
Value CHF4,940
Executive Director / Officer
Transaction date
Purchase
Price
61.75
Quantity 80
Value CHF4,940
Executive Director / Officer
Transaction date
Purchase
Price
61.75
Quantity 80
Value CHF4,940
Executive Director / Officer
Transaction date
Sale
Price
83.30
Quantity 3,000
Value CHF249,915
Non-Executive Director
Transaction date
Sale
Price
79.16
Quantity 1,776
Value CHF140,591
Non-Executive Director
Transaction date
Purchase
Price
56.10
Quantity 1,069
Value CHF59,971
Non-Executive Director
Transaction date
Purchase
Price
56.10
Quantity 1,248
Value CHF70,012
Executive Director / Officer
Transaction date
Purchase
Price
76.43
Quantity 200
Value CHF15,285
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-24 2026-06-24 S Sale Executive Director / Officer
98,715
181.18
CHF26,436 		98,715 181.18 CHF26,436
2026-06-11 2026-06-11 S Sale Executive Director / Officer
5,943
278.15
CHF3,989,991 		5,943 278.15 CHF3,989,991
2026-04-08 2026-04-08 S Sale Executive Director / Officer
88,063
60.75
CHF1,008,390 		88,063 60.75 CHF1,008,390
2025-11-16 2025-11-16 B Purchase Non-Executive Director
1
60,000.00
CHF60,000 		1 60,000.00 CHF60,000
2025-11-16 2025-11-16 B Purchase Non-Executive Director
1
75,000.00
CHF75,000 		1 75,000.00 CHF75,000
2025-11-11 2025-11-11 B Purchase Non-Executive Director
1
45,000.00
CHF45,000 		1 45,000.00 CHF45,000
2025-11-11 2025-11-11 B Purchase Non-Executive Director
1
70,000.00
CHF70,000 		1 70,000.00 CHF70,000
2025-11-10 2025-11-10 B Purchase Non-Executive Director
1
175,000.00
CHF175,000 		1 175,000.00 CHF175,000
2025-09-03 2025-09-03 B Purchase Executive Director / Officer
80
61.75
CHF4,940 		80 61.75 CHF4,940
2025-09-02 2025-09-02 B Purchase Executive Director / Officer
80
61.75
CHF4,940 		80 61.75 CHF4,940
2025-08-31 2025-08-31 B Purchase Executive Director / Officer
80
61.75
CHF4,940 		80 61.75 CHF4,940
2025-08-29 2025-08-29 B Purchase Executive Director / Officer
80
61.75
CHF4,940 		80 61.75 CHF4,940
2025-08-29 2025-08-29 B Purchase Executive Director / Officer
80
61.75
CHF4,940 		80 61.75 CHF4,940
2025-08-28 2025-08-28 B Purchase Executive Director / Officer
80
61.75
CHF4,940 		80 61.75 CHF4,940
2025-08-28 2025-08-28 B Purchase Executive Director / Officer
80
61.75
CHF4,940 		80 61.75 CHF4,940
2025-04-25 2025-04-25 S Sale Executive Director / Officer
3,000
83.30
CHF249,915 		3,000 83.30 CHF249,915
2025-03-21 2025-03-21 S Sale Non-Executive Director
1,776
79.16
CHF140,591 		1,776 79.16 CHF140,591
2025-01-02 2025-01-02 B Purchase Non-Executive Director
1,069
56.10
CHF59,971 		1,069 56.10 CHF59,971
2024-12-20 2024-12-20 B Purchase Non-Executive Director
1,248
56.10
CHF70,012 		1,248 56.10 CHF70,012
2024-12-04 2024-12-04 B Purchase Executive Director / Officer
200
76.43
CHF15,285 		200 76.43 CHF15,285
Explore more

More insider trading research around Vifor Pharma AG

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe